The orphan drug industry celebrated last year, as the Orphan Drug Act passed its 30-year anniversary mark. More recently, supporters had another reason to celebrate: Kurt Karst of the Hyman, Phelps & McNamara’s FDA Blog crunched the ‘orphan drug numbers’ and found that 2013 “was an across-the-board record breaking year for orphan drugs,†with 31 […]
written on 07.04.2014
Orphan Drugs: Overcoming Hurdles in 2014 for Another Record-Breaking Year
